Video

Educated Patient Multiple Myeloma Summit On-Demand: Nov. 21, 2020

Author(s):

CURE Media Group

View the full CURE®Educated Patient® Multiple Myeloma Summit here!

View the full CURE®Educated Patient® Multiple Myeloma Summit here!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Related Content
Image of two people with text.
August 20th 2025

Patients and Caregivers Aim to Raise Funds for Myeloma Research

Ryan Scott
cancer horizons image for podcast
August 20th 2025

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer: © stock.adobe.com.
August 20th 2025

Key Immune Cells Linked to Better Kidney Cancer Outcomes

Ashley Chan
Cancer Horizons podcast logo
August 20th 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe subtypes: © stock.adobe.com.
August 20th 2025

Clinical Trial Confirms Keytruda and Lenvima Benefit in Kidney Cancer

Russ Conroy
Stereotactic body radiotherapy costs less and has shown better safety compared with immunotherapy and tyrosine kinase inhibitors in patients kidney cancer: © stock.adobe.com
August 20th 2025

Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes

Tim Cortese